Renalytix Plc (RNLXY)
OTCMKTS
· Delayed Price · Currency is USD
0.260
+0.015 (6.12%)
Jan 14, 2025, 4:00 PM EST
Renalytix Revenue
Renalytix had revenue of $522.00K in the quarter ending September 30, 2024, with 13.73% growth. This brings the company's revenue in the last twelve months to $2.35M, down -18.70% year-over-year. In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M, down -32.74%.
Revenue (ttm)
2.35M
Revenue Growth
-18.70%
P/S Ratio
n/a
Revenue / Employee
23.06K
Employees
102
Market Cap
48.47M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 21.77M |
| Jun An Kang Group | 4.47M |